We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Handheld Blood Gas Electrolyte Analyzer Advances Point-of-Care Testing (POCT)

By LabMedica International staff writers
Posted on 04 Jul 2023
Print article
Image: The i-Check handheld blood gas electrolyte analyzer (Photo courtesy of B&E)
Image: The i-Check handheld blood gas electrolyte analyzer (Photo courtesy of B&E)

A vital factor for patients in emergency and critical care settings is their rapidly changing physiological state, which can deteriorate quickly and necessitate immediate diagnosis and clinical decisions for improving patient outcomes. Point-of-care testing (POCT) is a significant advancement in critical care settings, designed to provide decentralized, patient-centered healthcare. Quick access to blood measurements, especially blood gases, and electrolytes, can lead to better clinical outcomes. Now, a new handheld blood gas electrolyte analyzer designed to meet the urgency of clinical decision provides prompt POCT and improves patient outcomes while reducing therapeutic turnaround time (TTAT) and shortening door-to-clinical-decision time.

The newly-launched i-Check handheld blood gas electrolyte analyzer from B&E Biotechnology Co. Ltd. (Yantai, China) adopts microfluidic and electrochemical detection technology. Its single-use cartridge includes a plastic substrate, a multi-biosensor array, a calibrator pouch, a sample injection port, and a waste chamber. Notably, the multi-biosensor array is produced by silk-screen printing. The printing ink materials used comprise only carbon, silver, and insulation, without any noble metal, which significantly lowers the production cost compared to other manufacturers. Furthermore, special production technology enables its long-term stability to last 12 months under refrigeration. The i-Check handheld blood gas electrolyte analyzer requires only 95 μL of blood to measure pH, PCO2, PO2, K, Na, iCa, Hct, etc. in just one minute.

Among other benefits, the cartridge can be used immediately after removal from the refrigerator and does not need to be brought up to room temperature due to the efficient heating effect of the attached carbon heating film. It can rapidly increase the temperature of the electrode and flow path and maintain them at 37℃ when paired with an IR temperature sensor. Each cartridge has its own standard solution (calibrator), facilitating a one-point calibration, and eliminating the need for an additional reagent package. Calibration before sample injection is performed to prevent the impact of blood cell precipitation on Hct testing. Each cartridge also contains a unique RFID chip for quality control, effectively avoiding erroneous results from using expired cartridges. In a correlation experiment with a desktop blood gas analyzer, the i-Check excelled in test performance with correlation coefficients R2 all above 0.973 (n=76).

Related Links:
B&E Biotechnology Co. Ltd. 

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more